Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001571049-17-005588
Filing Date
2017-06-01
Accepted
2017-06-01 17:06:59
Documents
1
Period of Report
2017-05-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT t1701732_x6-f4.html 4  
1 OWNERSHIP DOCUMENT t1701732_x6-f4.xml 4 3981
  Complete submission text file 0001571049-17-005588.txt   5456
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 PINE STREET PHILADELPHIA PA 19106
Business Address
UPRICHARD DAVID C (Reporting) CIK: 0001239916 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 17885550